Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BCAX | AVLN |
|---|---|---|
| Price | $16.42 | $25.53 |
| Change today | ▼ 0.85% | ▲ 0.39% |
| Market cap | $1.09B | $1.13B |
| Return, 3 months | -44.7% | -11.7% |
| Return, year to date | -2.4% | – |
| Return, 1 year | -8.8% | – |
| P/E (TTM) | -5.3 | -11.0 |
| P/B | 2.3 | 2.8 |
| P/E percentile vs own 5y | 98th | 95th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -102.4% | -43.3% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -41.0% | -25.9% |
| Analyst target vs. price | +123.3% | +120.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 20 | 31 |
| 30-day volatility | 43.7% | 55.6% |
| Max drawdown, 1 year | -46.0% | -35.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
